VX-880

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VX-880, covering 2026-03-17 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant [Phase 3]

See pricing